GB8302374D0 - Nasal pharmaceutical compositions - Google Patents

Nasal pharmaceutical compositions

Info

Publication number
GB8302374D0
GB8302374D0 GB838302374A GB8302374A GB8302374D0 GB 8302374 D0 GB8302374 D0 GB 8302374D0 GB 838302374 A GB838302374 A GB 838302374A GB 8302374 A GB8302374 A GB 8302374A GB 8302374 D0 GB8302374 D0 GB 8302374D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
nasal pharmaceutical
nasal
compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB838302374A
Other versions
GB2114001A (en
GB2114001B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to CY149083A priority Critical patent/CY1490A/en
Priority to GB08302374A priority patent/GB2114001B/en
Publication of GB8302374D0 publication Critical patent/GB8302374D0/en
Publication of GB2114001A publication Critical patent/GB2114001A/en
Application granted granted Critical
Publication of GB2114001B publication Critical patent/GB2114001B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08302374A 1982-02-01 1983-01-28 Nasel pharmaceutical compositions Expired GB2114001B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CY149083A CY1490A (en) 1982-02-01 1983-01-28 Improvements in or relating to nasal pharmaceutical compositions
GB08302374A GB2114001B (en) 1982-02-01 1983-01-28 Nasel pharmaceutical compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01
GB08302374A GB2114001B (en) 1982-02-01 1983-01-28 Nasel pharmaceutical compositions

Publications (3)

Publication Number Publication Date
GB8302374D0 true GB8302374D0 (en) 1983-03-02
GB2114001A GB2114001A (en) 1983-08-17
GB2114001B GB2114001B (en) 1986-06-18

Family

ID=26281857

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08302374A Expired GB2114001B (en) 1982-02-01 1983-01-28 Nasel pharmaceutical compositions

Country Status (2)

Country Link
CY (1) CY1490A (en)
GB (1) GB2114001B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT396870B (en) * 1986-08-07 1993-12-27 Sandoz Ag Process for the production of a pharmaceutical formulation for the nasal administration of serotonin antagonists
IL91856A0 (en) * 1988-10-11 1990-06-10 Schiapparelli Salute Spa Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition

Also Published As

Publication number Publication date
GB2114001A (en) 1983-08-17
GB2114001B (en) 1986-06-18
CY1490A (en) 1990-02-16

Similar Documents

Publication Publication Date Title
GB8326565D0 (en) Pharmaceutical compositions
HK16090A (en) Pharmaceutical compositions
IL69892A0 (en) Pharmaceutical compositions comprising calcitonin
ZA834074B (en) Pharmaceutical composition
ZA833781B (en) Pharmaceutical compositions
EP0093551A3 (en) Pharmaceutical composition
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
PT77323A (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
DE3377696D1 (en) Pharmaceutical compositions
GB8302374D0 (en) Nasal pharmaceutical compositions
GB8328896D0 (en) Pharmaceutical composition
US4594359B1 (en) Pharmaceutical compositions
IL67822A0 (en) Nasal pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
GB8332653D0 (en) Pharmaceutical composition
GB8331068D0 (en) Pharmaceutical compositions
GB8329391D0 (en) Pharmaceutical compositions
GB8314540D0 (en) Pharmaceutical composition
DE3372706D1 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Effective date: 20030127